Sign in

You're signed outSign in or to get full access.

Susan M. Lewis

Director at STEPANSTEPAN
Board

About Susan M. Lewis

Susan M. Lewis, age 59, has served as an independent director of Stepan Company since 2024 with a current term expiring in 2027. She was previously Principal of Susan Lewis Consulting LLC (Mar 2021–Jul 2023) and Senior Vice President, Global Operations at Corteva, Inc. (Sep 2018–Mar 2021), following 30+ years at Dow Inc. leading operations, EHS, sustainability, risk management, Six Sigma, supply chain, process optimization, and capital projects . The Board determined Ms. Lewis is independent under NYSE standards; she serves on four standing committees (Audit; Compliance; Human Capital & Compensation; Nominating & Corporate Governance) and is financially literate .

Past Roles

OrganizationRoleTenureCommittees/Impact
Susan Lewis Consulting LLCPrincipalMar 2021 – Jul 2023Executive consulting; organizational redesign and transformation sponsorship
Corteva, Inc.SVP, Global OperationsSep 2018 – Mar 2021Global operations leadership
Dow Inc.Various leadership roles30+ yearsOperations, EHS, sustainability, risk management, Six Sigma, supply chain, process optimization, capital project management; M&A and transformation sponsorship

External Roles

  • No other current public company directorships disclosed for Ms. Lewis in the proxy .

Board Governance

CommitteeRole2024 MeetingsNotes
AuditMember5All members independent and financially literate; Burgess (Chair); Lewis member; financial expert designation given to Burgess and Wehmer
ComplianceMember5Oversees legal/regulatory compliance and ethics; Dearth (Chair); Lewis member
Human Capital & CompensationMember9Oversees exec pay, HCM; Reed (Chair); Lewis member; no interlocks or insider participation among members in 2024
Nominating & Corporate GovernanceMember5Board composition/governance oversight; Delgado (Chair); Lewis member
  • Independence: Board determined Ms. Lewis is independent; all members of standing committees meet independence standards .
  • Attendance: Board held six meetings in 2024; all directors attended >75% of Board and committee meetings; all directors attended the 2024 Annual Meeting .
  • Executive sessions: Six independent director executive sessions held in 2024 .

Fixed Compensation

ComponentAmountNotes
Annual Director Retainer (cash)$100,000Non-Employee Directors
Committee Chair Fees$20,000 per chairAudit, Compensation, Compliance, Nominating chairs
Chairman of the Board Fee$225,000Non-executive Chairman
Lead Independent Director Fee$20,000Additional annual fee
Susan M. Lewis – Fees Earned (2024)$62,637Prorated given start date Feb 15, 2024

Performance Compensation

Equity ComponentSharesGrant DateFair ValueVestingDeferral
Annual Stock Award1,396Apr 30, 2024$124,984Vested upon grantDirectors may elect to defer under plan
  • Directors did not receive stock options in 2024; equity awards for directors are time-based and not tied to performance metrics .

Other Directorships & Interlocks

ItemDetail
Other public boardsNone disclosed for Ms. Lewis
Compensation Committee interlocksNone; no member was an officer/employee; no related party participation in 2024

Expertise & Qualifications

  • Global operations, EHS, sustainability, risk management, Six Sigma, supply chain, process optimization, capital project management; organizational redesign and M&A/transformation projects .
  • Financial literacy and service on Audit Committee .
  • Broad governance exposure across compliance, compensation, and nominating structures through committee service .

Equity Ownership

MetricValueAs of
Beneficial ownership (shares)1,896Mar 3, 2025
Ownership % of outstandingLess than 1%Based on 22,554,929 shares outstanding
Director equity structureAnnual stock award vested at grant; no options granted in 2024Program overview
Director stock ownership guideline5x annual retainer; 5-year compliance period; all Non-Employee Directors in compliance or on progress trackPolicy and status
Hedging/short-selling policyProhibited for directors under Insider Trading PolicyPolicy

Note: The ownership table does not disclose any pledging by Ms. Lewis; her entry shows 1,896 shares without pledge footnotes .

Governance Assessment

  • Committee engagement: Ms. Lewis serves on all four standing committees (Audit, Compliance, Human Capital & Compensation, Nominating), indicating high engagement and broad governance remit .
  • Independence and attendance: Determined independent; Board meetings held six times in 2024 with >75% attendance for all directors; independent executive sessions held six times, supporting robust oversight .
  • Shareholder support: Elected in 2024 with 18,821,247 votes “FOR” vs 87,784 “AGAINST” (broker non-votes 1,701,740), demonstrating strong investor confidence .
  • Director pay alignment: Cash retainer is modest; equity grants are time-based and vested at grant (typical for directors), with stock ownership guidelines at 5x retainer to drive alignment; all non-employee directors are in compliance or progressing per policy .
  • Conflicts/related-party exposure: No related-party transactions disclosed involving Ms. Lewis; Audit Committee oversees related party approvals under a formal policy; 2024 disclosed related party employment relates to a Stepan family member, not Ms. Lewis .
  • RED FLAGS: None evident specific to Ms. Lewis—no low attendance, no disclosed pledging/hedging, no related-party transactions; director equity is not performance-based (typical for directors), but immediate vesting reduces at-risk structure versus performance-conditioned awards (contextual, not a red flag) .
  • Say-on-Pay context: Company’s 2024 Say-on-Pay support was 96% of votes cast, indicating broader investor approval of compensation governance at Stepan .